INNATE PHARMA SA-SPONS ADR (IPHA) Stock Overview

What is the stock price of INNATE PHARMA SA-SPONS ADR today?

The current stock price of IPHA is 2.15 USD. The price increased by 0.47% in the last trading session.

What is the ticker symbol for INNATE PHARMA SA-SPONS ADR stock?

The exchange symbol of INNATE PHARMA SA-SPONS ADR is IPHA and it is listed on the Nasdaq exchange.

On which exchange is IPHA stock listed?

IPHA stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for INNATE PHARMA SA-SPONS ADR stock?

7 analysts have analysed IPHA and the average price target is 6.12 USD. This implies a price increase of 184.54% is expected in the next year compared to the current price of 2.15. Check the INNATE PHARMA SA-SPONS ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is INNATE PHARMA SA-SPONS ADR worth?

INNATE PHARMA SA-SPONS ADR (IPHA) has a market capitalization of 198.16M USD. This makes IPHA a Micro Cap stock.

How many employees does INNATE PHARMA SA-SPONS ADR have?

INNATE PHARMA SA-SPONS ADR (IPHA) currently has 168 employees.

What are the support and resistance levels for INNATE PHARMA SA-SPONS ADR (IPHA) stock?

INNATE PHARMA SA-SPONS ADR (IPHA) has a support level at 2.15 and a resistance level at 2.25. Check the full technical report for a detailed analysis of IPHA support and resistance levels.

Is INNATE PHARMA SA-SPONS ADR (IPHA) expected to grow?

The Revenue of INNATE PHARMA SA-SPONS ADR (IPHA) is expected to decline by -8.95% in the next year. Check the estimates tab for more information on the IPHA EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy INNATE PHARMA SA-SPONS ADR (IPHA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of IPHA, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of IPHA, evaluating the profitability, health, valuation and growth aspects
• INNATE PHARMA SA-SPONS ADR (IPHA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• INNATE PHARMA SA-SPONS ADR (IPHA) Sales and EPS estimates to see what analysts future expectations are.
• INNATE PHARMA SA-SPONS ADR (IPHA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• INNATE PHARMA SA-SPONS ADR (IPHA) Insider and Institutional Ownership to learn about the owners and their transactions.
• INNATE PHARMA SA-SPONS ADR (IPHA) Stock Chart to make your own analysis
• INNATE PHARMA SA-SPONS ADR (IPHA) Latest news and press-releases to stay up to date.

Does INNATE PHARMA SA-SPONS ADR (IPHA) stock pay dividends?

IPHA does not pay a dividend.

When does INNATE PHARMA SA-SPONS ADR (IPHA) report earnings?

INNATE PHARMA SA-SPONS ADR (IPHA) will report earnings on 2025-11-13.

What is the Price/Earnings (PE) ratio of INNATE PHARMA SA-SPONS ADR (IPHA)?

INNATE PHARMA SA-SPONS ADR (IPHA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.61).

What is the Short Interest ratio of INNATE PHARMA SA-SPONS ADR (IPHA) stock?

The outstanding short interest for INNATE PHARMA SA-SPONS ADR (IPHA) is 0.07% of its float. Check the ownership tab for more information on the IPHA short interest.